Opportunity timeline
In plain English
The Department of Energy wants to license a new technology that improves how therapeutic gases are delivered for medical treatments. This platform uses a controlled-release system to target gases like those used in oncology or cardiovascular care, reducing side effects and improving effectiveness. They are looking for companies to license this patent-pending technology for commercial development, not for services to develop it further.
About this opportunity
This technology from scientists at Los Alamos National Laboratory represents a novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these…
Time remaining
Closes Dec 4, 2026
Related Opportunities

FY27 SIR-Spheres Y90 Resin Microspheres

FY27-28 Pediatric Flu Vaccines

FY27-28 Adult Flu Vaccines

Tacrolimus Capsules

FDG Radiopharmaceutical
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-488492

